Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
3.920
-0.300 (-7.11%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $10.29 million as of October 23, 2026. It is the 41,265th most valuable company in the world and the 5,580th biggest in the United States. Its market cap has increased by 31.97% in one year.
Market Cap
10.29M
Enterprise Value
-18.42M
1-Year Change
31.97%
Global Rank
Country Rank
#5,580 United States
Category
ChartMarket Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.30M to $10.29M, a decrease of -60.86%. That is a compound annual growth rate of -10.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 10.30M | 94.34% |
| Dec 31, 2025 | 5.30M | -18.46% |
| Dec 31, 2024 | 6.50M | 182.61% |
| Dec 29, 2023 | 2.30M | -60.34% |
| Dec 30, 2022 | 5.80M | -89.66% |
| Dec 31, 2021 | 56.10M | 131.82% |
| Dec 31, 2020 | 24.20M | -2.81% |
| Dec 31, 2019 | 24.90M | -25.89% |
| Dec 31, 2018 | 33.60M | 27.76% |
| Jul 30, 2018 | 26.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 12.04M |
| AEON Biopharma | 11.66M |
| Passage Bio | 11.29M |
| Cellectar Biosciences | 11.06M |
| CytoMed Therapeutics | 10.97M |
| BioLineRx | 10.57M |
| Purple Biotech | 10.49M |
| Intensity Therapeutics | 10.41M |